Grupo para la caracterización molecular de las neoplasias hematológicas
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Reino UnidoPublications en collaboration avec des chercheurs de Cambridge University Hospitals NHS Foundation Trust (2)
2024
-
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Blood, Vol. 143, Núm. 17, pp. 1713-1725
2022
-
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nature Medicine, Vol. 28, Núm. 2, pp. 325-332